Human Papillomavirus Vaccination Rates in Young Cancer Survivors

PURPOSE: Cancer survivors are at high risk for human papillomavirus (HPV)-related morbidities; we estimated the prevalence of HPV vaccine initiation in cancer survivors versus the US population and examined predictors of noninitiation. METHODS: Participants included 982 cancer survivors (9 to 26 yea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Klosky, James L., Hudson, Melissa M., Chen, Yanjun, Connelly, James A., Wasilewski-Masker, Karen, Sun, Can-Lan, Francisco, Liton, Gustafson, Laura, Russell, Kathryn M., Sabbatini, Gina, Flynn, Jessica S., York, Jocelyn M., Giuliano, Anna R., Robison, Leslie L., Wong, F. Lennie, Bhatia, Smita, Landier, Wendy
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2017
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5662846/
https://ncbi.nlm.nih.gov/pubmed/28837404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.74.1843
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars